Qingdao Vland Biotech INC
SSE:603739

Watchlist Manager
Qingdao Vland Biotech INC Logo
Qingdao Vland Biotech INC
SSE:603739
Watchlist
Price: 14.15 CNY 0.78% Market Closed
Market Cap: 3.6B CNY

Wall Street
Price Targets

Price Targets Summary
Qingdao Vland Biotech INC

There are no price targets for Qingdao Vland Biotech INC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Qingdao Vland Biotech INC Competitors:
Price Targets
DVAX
Dynavax Technologies Corp
38% Upside
RXRX
Recursion Pharmaceuticals Inc
73% Upside
2162
KeyMed Biosciences Inc
59% Upside
MRUS
Merus NV
11% Upside
VRTX
Vertex Pharmaceuticals Inc
10% Upside
251120
Bio-FD&C Co Ltd
23% Upside
RIGL
Rigel Pharmaceuticals Inc
7% Upside
KURA
Kura Oncology Inc
229% Upside

Revenue
Forecast

Revenue Estimate
Qingdao Vland Biotech INC

For the last 8 years the compound annual growth rate for Qingdao Vland Biotech INC's revenue is 7%. The projected CAGR for the next 3 years is 10%.

7%
Past Growth
10%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Qingdao Vland Biotech INC

Operating Income forecast
is not available for
Qingdao Vland Biotech INC

Net Income
Forecast

Net Income Estimate
Qingdao Vland Biotech INC

For the last 8 years the compound annual growth rate for Qingdao Vland Biotech INC's net income is -3%. The projected CAGR for the next 3 years is 25%.

-3%
Past Growth
25%
Estimated Growth
Estimates Accuracy
-25%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Qingdao Vland Biotech INC's stock price target?
Not Available

Qingdao Vland Biotech INC doesn't have any price targets made by Wall Street professionals.

What is Qingdao Vland Biotech INC's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Qingdao Vland Biotech INC's revenue is 7%. The projected CAGR for the next 3 years is 10%.

What is Qingdao Vland Biotech INC's Net Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Qingdao Vland Biotech INC's net income is -3%. The projected CAGR for the next 3 years is 25%.

Back to Top